| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4030961 | Ophthalmology | 2006 | 5 Pages |
Abstract
Treatment of post-LASIK nontuberculous mycobacteria remains a challenge. Institution of combination therapy including fortified amikacin, clarithromycin 1%, and a fourth-generation fluoroquinolone appeared to be beneficial in this patient.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Rola N. MD, Baha MD, Haytham I. MD, Randa MD, Johnny M. MD,